Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosravuconazole vs Itraconazole for Eumycetoma
NCT03086226Phase 2Completed
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- May 2017
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fosravuconazole in eumycetoma, sponsored by Drugs for Neglected Diseases initiative. Started May 2017; status: completed.
02
Drugs
fosravuconazole
03
Conditions
eumycetoma
Beyond the preview
Go deeper on NCT03086226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03086226.